Evidence map›Paper›PMID 32534982›Full record

ArticleBrazilian journal of otorhinolaryngology

Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.

Eduardo Macoto Kosugi, Joel Lavinsky, Fabrizio Ricci Romano, Marco Aurélio Fornazieri, Gabriela Ricci Luz-Matsumoto, Marcus Miranda Lessa, Otávio Bejzman Piltcher, Geraldo Druck Sant'Anna

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05461365 (Intranasal Insulin for COVID-19-related Smell Loss), which is not on this map. Cited by 42 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 5 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05461365 phase3completednot on this map

Intranasal Insulin for COVID-19-related Smell Loss

TypeinterventionalSponsorUniversidad PanamericanaRan2021 to 2021Enrolled27ConditionsAnosmia, Smell Loss, Paraosmia, HyposmiaArmsInsulin
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 5 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Intranasal insulin for COVID-19-related smell loss.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  12. Article
  13. COVID-19 and Mental Health: A "Pandemic Within a Pandemic".Advances in experimental medicine and biology · 2024
    Review
  14. Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eduardo Macoto KosugiAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil; Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF), São Paulo, SP, Brazil. Electronic address: edumacoto@gmail.com.
Joel LavinskyAssociação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF), São Paulo, SP, Brazil.
Fabrizio Ricci RomanoAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil; Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF), São Paulo, SP, Brazil.
Marco Aurélio FornazieriAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil.
Gabriela Ricci Luz-MatsumotoAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil.
Marcus Miranda LessaAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil.
Otávio Bejzman PiltcherAcademia Brasileira de Rinologia (ABR), São Paulo, SP, Brazil.
Geraldo Druck Sant'AnnaAssociação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF), São Paulo, SP, Brazil.
Brazilian Academy of Sciences · BRAssociação Brasileira de Alergia e Imunologia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSudden olfactory dysfunction is a new symptom related to COVID-19, with little data on its duration or recovery rate.

objectiveTo characterize patients with sudden olfactory dysfunction during the COVID-19 pandemic, especially their recovery data.

methodsAn online survey was conducted by the Brazilian Society of Otorhinolaryngology and Cervico-Facial Surgery, and Brazilian Academy of Rhinology, including doctors who assessed sudden olfactory dysfunction patients starting after February 1st, 2020. Participants were posteriorly asked by e-mail to verify data on the recovery of sudden olfactory loss and test for COVID-19 at the end of the data collection period.

results253 sudden olfactory dysfunction patients were included, of which 59.1% were females with median age of 36 years, with a median follow-up period of 31 days. 183 patients (72.3%) had been tested for COVID-19, and of those 145 (79.2%) tested positive. Patients that tested positive for COVID-19 more frequently showed non-specific inflammatory symptoms (89.7% vs. 73.7%; p=0.02), a lower rate of total recovery of sudden olfactory dysfunction (52.6% vs. 70.3%; p=0.05) and a longer duration to achieve total recovery (15 days vs. 10 days; p=0.0006) than the ones who tested negative for COVID-19. Considering only positive-COVID-19 patients, individuals with sudden hyposmia completely recovered more often than the ones with sudden anosmia (68.4% vs. 50.0%; p=0.04).

conclusionPositive-COVID-19 patients with sudden olfactory dysfunction showed lower total recovery rate and longer duration than negative-COVID-19 patients. Additionally, total recovery was seen more frequently in positive-COVID-19 patients with sudden hyposmia than the ones with sudden anosmia.

Indexed as

BetacoronavirusPandemicsAdultBrazilCoronavirus InfectionsCOVID-19FemaleHumansMaleOlfaction DisordersPneumonia, ViralSARS-CoV-2AnosmiaCOVID-19Olfactory disordersTranstornos do olfato

Identifiers

PMID32534982
PMCPMC7247498
OpenAlexW3026824231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.